LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 2 of 166
Next
>>
>
26 to 50 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Relative Growth Rate After Treatment
BT-20	WZ-4-145	0.04	uM	LJP6	72	hr	1334	3309	3970	0.8334	0.7490
BT-20	XMD16-144	0.04	uM	LJP5	72	hr	1334	3824	3970	0.9632	0.9445
BT-20	Brivanib	0.04	uM	LJP5	72	hr	1334	4008	3970	1.0093	1.0141
BT-20	Buparlisib	0.04	uM	LJP5	72	hr	1334	4150	3970	1.0451	1.0679
BT-20	BX-912	0.04	uM	LJP5	72	hr	1334	3739	3970	0.9417	0.9122
BT-20	Canertinib	0.04	uM	LJP6	72	hr	1334	3494	3970	0.8801	0.8194
BT-20	Celastrol	0.04	uM	LJP6	72	hr	1334	4023	3970	1.0132	1.0199
BT-20	CGP60474	0.04	uM	LJP5	72	hr	1334	3530	3970	0.8891	0.8329
BT-20	CGP60474	0.04	uM	LJP6	72	hr	1334	782	3970	0.1969	-0.2097
BT-20	CHIR-99021	0.04	uM	LJP6	72	hr	1334	3515	3970	0.8853	0.8272
BT-20	CP724714	0.04	uM	LJP5	72	hr	1334	3801	3970	0.9572	0.9356
BT-20	CP466722	0.04	uM	LJP5	72	hr	1334	4240	3970	1.0678	1.1022
BT-20	Crizotinib	0.04	uM	LJP5	72	hr	1334	3325	3970	0.8374	0.7551
BT-20	Momelotinib	0.04	uM	LJP5	72	hr	1334	3991	3970	1.0051	1.0077
BT-20	Dasatinib	0.04	uM	LJP5	72	hr	1334	3455	3970	0.8701	0.8043
BT-20	Dasatinib	0.04	uM	LJP6	72	hr	1334	2913	3970	0.7337	0.5988
BT-20	Dovitinib	0.04	uM	LJP5	72	hr	1334	3395	3970	0.8550	0.7815
BT-20	Enzastaurin	0.04	uM	LJP5	72	hr	1334	3740	3970	0.9419	0.9125
BT-20	Erlotinib	0.04	uM	LJP5	72	hr	1334	3679	3970	0.9267	0.8895
BT-20	Foretinib	0.04	uM	LJP5	72	hr	1334	3950	3970	0.9948	0.9922
BT-20	R406	0.04	uM	LJP6	72	hr	1334	3713	3970	0.9351	0.9023
BT-20	Pictilisib	0.04	uM	LJP6	72	hr	1334	3004	3970	0.7566	0.6334
BT-20	Gefitinib	0.04	uM	LJP6	72	hr	1334	4187	3970	1.0546	1.0822
BT-20	Geldanamycin	0.04	uM	LJP5	72	hr	1334	1781	3970	0.4486	0.1694
BT-20	Geldanamycin	0.04	uM	LJP6	72	hr	1334	2191	3970	0.5519	0.3251

|<
<<
Previous
Page 2 of 166
Next
>>
>
26 to 50 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)